advertisement
Huang Y 38
Showing records 1 to 25 | Display all abstracts from Huang Y80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Kumar A
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Gong B
Genetics in Medicine 2019; 21: 2345-2354
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Liu Y
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Zastrow DB
American Journal of Medical Genetics, Part A 2019; 179: 966-977
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Zhao J
Frontiers in pharmacology 2019; 10: 679
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Zhang H
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Kravets EJ
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang L
Genetics in Medicine 2019; 21: 2345-2354
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Zhong X; Wei Q
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Beleford D
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Chen Y
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Ruzhnikov MRZ
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Shi Y
Genetics in Medicine 2019; 21: 2345-2354
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
Huang Y
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Grove ME
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Tam PO; Zhu X
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Dries AM
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Huang Y
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Kohler JN
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Lei B
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Waggott DM; Yang Y
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Sundaresan P; Li X
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
Huang Y
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axis
Jiang L
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review
; Mackenzie KM
American Journal of Medical Genetics, Part A 2019; 179: 966-977
